Dengue fever, a mosquito-borne viral disease common in tropical and subtropical regions, presents with varying severity. Many infections are asymptomatic or mild. Symptomatic cases, appearing 3-14 days post-infection, involve high fever, headache, vomiting, muscle/joint pain, itching, and rash. Recovery usually occurs within 2-7 days. A small percentage of cases progress to severe dengue, characterized by bleeding, low platelet count, plasma leakage, and dangerously low blood pressure.
Bangladesh faces a deadly dengue fever outbreak exacerbated by climate change, particularly impacting coastal areas. Urgent health education is crucial for preventing the spread of vector-borne diseases as 394 new cases reported.
In 1953, the severe hemorrhagic form of dengue was first reported in the Philippines.
Since 1998, The Philippines has an awareness month in June.
In 2010, the idea for International Anti-Dengue Day was first agreed upon.
The World Health Organization (WHO) recorded a ten-fold increase in dengue cases between 2010 and 2019.
In 2011, the first International Anti-Dengue Day event was held in Jakarta, Indonesia.
In 2012, an International Anti-Dengue Day event was held in Yangon, Myanmar.
A study estimated that in 2013 the global burden of dengue amounted to US$8.9 billion.
In 2013, an International Anti-Dengue Day event was held in Vietnam.
In 2013, approximately 390 million dengue infections occurred, with 500,000 cases developing severe symptoms and 25,000 resulting in death.
In 2015, Dengvaxia (formerly CYD-TDV) became available and was approved for use in the US, EU, and some Asian and Latin American countries.
In 2016, Dengvaxia became commercially available, but its use was recommended only for preventing re-infection in individuals previously infected with dengue.
As of 2019, efforts are ongoing to make International Anti-Dengue Day a global event.
The World Health Organization (WHO) recorded a ten-fold increase in dengue cases between 2010 and 2019.
In December 2022, Qdenga (formerly TAK-003) was approved for use in the European Union after completing clinical trials.
In 2022, Qdenga became available and suitable for adults, adolescents, and children from four years of age.
As of March 2023, dengue is endemic in more than 100 countries across nearly every continent, excluding Antarctica.
In October 2023, the first confirmed symptomatic case of locally acquired dengue in the US was identified in California.
During 2023, over 5 million dengue infections were reported, accompanied by more than 5,000 dengue-related deaths.
As of March 2024, two vaccines, Dengvaxia and Qdenga, exist to provide protection against dengue infection.
As of July 2024, there is no specific antiviral treatment available for dengue fever.
Myanmar also known as Burma is the largest country in...
The World Health Organization WHO is a specialized agency of...
Indonesia is a Southeast Asian and Oceanian country the world's...
Vietnam officially the Socialist Republic of Vietnam is located in...
3 months ago Will Cain's Radio Show: Discussions and Insights from March 10th and 11th
2 months ago Dejounte Murray Walking Again; Popovich's Spurs Legacy and Coaching Future Discussed.
1 hour ago Carmelo Anthony avoids 1-on-1 with Michael Beasley says Lance Stephenson: "Nobody wants to lose"
1 month ago Brandon Aiyuk Trade Rumors: Steelers Interest, Cowboys Potential, and 49ers Draft History
Alexandria Ocasio-Cortez commonly known as AOC is a prominent American politician and activist She has served as the U S...
Impeachment is a formal process where a legislative body brings charges of misconduct against a public official It is a...
Sergio Gor is a Maltese American businessman and political operative...
Kristi Noem is an American politician who has served as...
Cristiano Ronaldo often called CR is a Portuguese professional footballer...
Jupiter is the fifth and largest planet from the Sun...
Benjamin Netanyahu is a prominent Israeli politician currently serving as...
Donald John Trump is an American politician media personality and...